Marculescu Rodrig, Vanura Katrina, Montpellier Bertrand, Roulland Sandrine, Le Trang, Navarro Jean-Marc, Jäger Ulrich, McBlane Fraser, Nadel Bertrand
Department of Internal Medicine I, Division of Hematology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
DNA Repair (Amst). 2006 Sep 8;5(9-10):1246-58. doi: 10.1016/j.dnarep.2006.05.015. Epub 2006 Jun 23.
A large number of lymphoid malignancies is characterized by specific chromosomal translocations, which are closely linked to the initial steps of pathogenesis. The hallmark of these translocations is the ectopic activation of a silent proto-oncogene through its relocation at the vicinity of an active regulatory element. Due to the unique feature of lymphoid cells to somatically rearrange and mutate receptor genes, and to the corresponding strong activity of the immune enhancers/promoters at that stage of cell development, B- and T-cell differentiation pathways represent propitious targets for chromosomal translocations and oncogene activation. Recent progress in the understanding of the V(D)J recombination process has allowed a more accurate definition of the translocation mechanisms involved, and has revealed that V(D)J-mediated translocations result both from targeting mistakes of the recombinase, and from illegitimate repair of the V(D)J recombination intermediates. Surprisingly, V(D)J-mediated translocations turn out to be restricted to two specific sub-types of lymphoid malignancies, T-cell acute lymphoblastic leukemias, and a restricted set of mature B-cell Non-Hodgkin's lymphomas.
大量淋巴样恶性肿瘤的特征是特定的染色体易位,这些易位与发病机制的初始步骤密切相关。这些易位的标志是通过沉默原癌基因重新定位到活跃调控元件附近而导致其异位激活。由于淋巴样细胞具有体细胞重排和突变受体基因的独特特性,以及在细胞发育该阶段免疫增强子/启动子相应的强活性,B细胞和T细胞分化途径成为染色体易位和癌基因激活的有利靶点。对V(D)J重组过程理解的最新进展使得对所涉及的易位机制有了更准确的定义,并揭示了V(D)J介导的易位既源于重组酶的靶向错误,也源于V(D)J重组中间体的异常修复。令人惊讶的是,V(D)J介导的易位仅限于两种特定亚型的淋巴样恶性肿瘤,即T细胞急性淋巴细胞白血病和一组受限的成熟B细胞非霍奇金淋巴瘤。